Global CDSS Market
Global Clinical Decision Support Systems (CDSS) Market Size Doubles to Touch USD 9.8 Billion by 2029
Published | 20 October 2023
Global clinical decision support systems (CDSS) market is gaining traction because of the increasing healthcare data and growing adoption of electronic health records (EHRs).
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global clinical decision support systems (CDSS) market size at USD 4.78 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the Global clinical decision support systems market size to grow at a CAGR of 10.74% reaching a value of USD 9.76 billion by 2029. The increased usage of information technologies such as big data, cloud computing, and mHealth tools, as well as favorable government efforts and investments, are major growth factors for the global clinical decision support systems (CDSS) market.
Global Clinical Decision Support Systems (CDSS) Market – Overview
A clinical decision support system (CDSS) is a program that analyzes data to assist healthcare practitioners in making decisions and providing better patient care. CDS is a collection of tools designed to improve clinical decision-making. These tools include automated alerts and reminders to care professionals and patients, clinical recommendations, condition-specific order sets, and targeted patient data reports and summaries. A clinical decision support system (CDSS) is designed to improve healthcare delivery by augmenting medical choices with targeted clinical knowledge, health data, and other patient information.
Sample Request @ https://www.blueweaveconsulting.com/report/clinical-decision-support-systems-market/report-sample
Global Clinical Decision Support Systems (CDSS) Market
Segmental Information
Global Clinical Decision Support Systems (CDSS) Market – By Mode of Delivery
Based on the mode of delivery, the global clinical decision support systems (CDSS) market is segmented into cloud-based CDSS and on-premises CDSS. The on-premises CDSS accounted for the largest market share during the period of 2019–2022. However, the cloud-based CDSS systems are projected to register growth at a higher CAGR during the forecast period, owing to the rapid development of information technology in the healthcare sector. The favorable characteristics of cloud-based systems, such as cost-effectiveness, reliability, and remote accessibility, significantly influence their growing market.
Impact of COVID-19 on Global Clinical Decision Support Systems (CDSS) Market
The use of the clinical decision support system (CDSS) spiked during the COVID-19 pandemic because of its quick diagnosis and management among people with symptoms. The healthcare industry witnessed a sudden shift towards mHealth and remote patient monitoring due to the surge in hospital-acquired infections and the significant decline in patient visits due to the overburdening of healthcare resources. The CDSS system assists healthcare professionals in the remote diagnosis and monitoring of both COVID-19 patients as well as long-term chronic patients.
Competitive Landscape
Major players operating in the global clinical decision support systems (CDSS) market include Cerner Corporation, IBM, Change Healthcare, Medical Information Technology Inc., Koninklijke Philips NV, Siemens Healthcare, Allscripts Healthcare Solutions Inc., Wolters Kluwer NV, Mckesson Corporation, Zynx Health Inc., Elsevier, NextGen Healthcare Inc., Agfa-Gevaert Group, and Athenahealth Inc.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Clinical Decision Support Systems (CDSS) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Clinical Decision Support Systems (CDSS) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
info@blueweaveconsulting.com
Get Help
Related Report
Publish Date: October 2023
Increasing healthcare data and growing adoption of electronic health records (EHRs) are expected to boost the growth of the global clinical decision support systems (CDSS) market during the forecast period between 2023 and 2029.
Relevant Press Releases
- India E Pharmacy Market to Witness Over 30% CAGR
- Global Patient Handling Equipment Market Awaits a Bright Future: Projected to Grow at a CAGR of 8.3% in the Forecast Period
- Europe Pharmacy Automation Market Size Set to Grow at Significant CAGR of 9.49% to Reach USD 2.67 Billion During 2023–2029
- UAE Nutraceuticals Market Size Set to Expand at Significant CAGR of 9.18% During 2023–2029, Touching USD 5.64 Billion by 2029
- United States Direct-to-Consumer (DTC) Genetic Testing Market Size More Than Doubles to Touch USD 2.33 Billion by 2029